Apart from the HOX genes, a recent study reported that the outcome of KRAS mutations and the status of DNA mismatch repair genes in patients with stage III colon cancer should be interpreted in the context of the primary tumour location with regard to the proximal versus distal colon53. This evidence concerns the gene KRAS and neoplasm.